US Patent No: 8,101,205

Number of patents in Portfolio can not be more than 2000

Controlled release composition

ALSO PUBLISHED AS: 20100048481

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition.) of the therapeutic protein is smaller than 2, preferably smaller than 1.5.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
FUJIFILM MANUFACTURING EUROPE B.V.TILBURG57

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bouwstra, Jan Bastiaan Bilthoven, NL 88 160
Hennink, Wilhelmus Everhardus Waddinxveen, NL 28 126
Jiskoot, Wim - 5 2
Kluijtmans, Sebastianus Gerardus - 10 3
Sutter, Marc - 6 2

Cited Art Landscape

Patent Info (Count) # Cites Year
 
FUJIFILM MANUFACTURING EUROPE B.V. (11)
6,150,081 Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof 21 1998
2007/0004,034 Process for coating cell-culture support 9 2003
7,517,954 RGD-enriched gelatine-like proteins with enhanced cell binding 9 2004
2006/0241,032 Rgd-enriched gelatine-like proteins with enhanced cell binding 9 2004
2006/0204,511 Use of recombinant or synthetic gelatin as stabiliser in vaccines 5 2004
2007/0031,501 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions 13 2004
2008/0107,666 Non-Glycosylated Recombinant Collagen-Like Polypeptides 7 2006
2008/0113,910 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING 8 2007
2008/0114,078 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING 8 2007
2008/0167,446 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING 8 2007
2008/0274,957 RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING 8 2007
 
FIBROGEN, INC. (4)
6,992,172 Recombinant gelatins 55 2000
2006/0147,501 Collagen compositions and biomaterials 12 2004
2005/0058,703 Gelatin capsules 7 2004
2009/0143,568 Recombinant gelatins 7 2008
 
GEL-DEL TECHNOLOGIES, INC. (4)
2002/0028,243 Protein matrix materials, devices and methods of making and using thereof 112 2001
2003/0007,991 Devices including protein matrix materials and methods of making and using thereof 28 2001
2002/0106,410 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices 10 2001
2005/0147,690 Biocompatible protein particles, particle devices and methods thereof 32 2004
 
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (3)
5,023,082 Sustained-release pharmaceutical compositions 93 1988
5,002,769 Compositions for the sustained-release of chlorhexidine 23 1989
5,897,879 Sustained-release pharmaceutical system for the delivery of antioxidants 18 1997
 
2120812 ONTARIO INC. (2)
2004/0237,663 Delivery systems for functional ingredients 17 2003
2005/0208,141 Delivery systems for functional ingredients 14 2005
 
AMGEN INC. (2)
5,399,361 Collagen-containing sponges as drug delivery compositions for proteins 74 1994
5,512,301 Collagen-containing sponges as drug delivery compositions for proteins 33 1994
 
COVALON TECHNOLOGIES INC. (2)
2006/0068,013 Non-adhesive elastic gelatin matrices 15 2005
2007/0009,580 Non-adhesive hydrogels 7 2005
 
Alfatec-Pharma GmbH (1)
6,068,854 Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form 14 1996
 
BATTELLE MEMORIAL INSTITUTE (1)
2006/0024,346 Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds 12 2004
 
CELLTRAN LIMITED (1)
6,458,386 Medicaments based on polymers composed of methacrylamide-modified gelatin 34 2000
 
DEUTSCHE GELATINE-FABRIKEN STOESS AG (1)
5,733,994 Biodegradable, water-resistant polymer material 13 1996
 
GEL-DEL TECHNOLOGIES (1)
6,342,250 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices 46 1998
 
Ihara & Company Ltd. (1)
2006/0177,492 Collagen gel and process of producing the same 7 2005
 
INTELLIPHARMACEUTICS CORP. (1)
2006/0024,361 Disintegrant assisted controlled release technology 20 2004
 
KAKEN PHARMACEUTICAL CO., LTD. (1)
6,831,058 Crosslinked gelatin gel preparation containing basic fibroblast growth factor 12 1995
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (1)
2006/0121,609 Gradient scaffolding and methods of producing the same 18 2005
 
MATRIX PHARMACEUTICAL, INC. (1)
5,597,578 TGF-.beta. protein compositions for inhibition of cell proliferation 37 1994
 
MEDGEL CORPORATION (1)
2006/0251,719 Sustained-release hydrogel preparation 9 2004
 
SPINE WAVE, INC. (1)
6,140,072 Functional recombinantly prepared synthetic protein polymer 32 1995
 
SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (1)
4,855,134 Sustained-release preparation 26 1986
 
Other [Check patent profile for assignment information] (4)
2003/0064,074 Recombinant gelatins in vaccines 25 2002
2005/0238,663 Recombinant stabilizer botulinum toxin pharmaceutical compositions 12 2004
2007/0190,153 Delivery systems for non-steroidal anti-inflammatory drugs (nsaids) 8 2004
2007/0196,496 Delivery systems for functional ingredients 9 2006

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
DANISCO US INC. (1)
8,309,334 Method for producing highly impact-resistant granules 0 2008
 
FUJIFILM MANUFACTURING EUROPE B.V. (1)
8,357,397 Controlled release composition comprising a recombinant gelatin 0 2008

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 24, 2015
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 24, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00